Skip to main content
Elsevier
View Cart

AI and Precision Oncology

Innovations in Diagnosis and Drug Development

  • 1st Edition - November 1, 2026
  • Latest edition
  • Editors: Arun Kumar Singh, Prateek Agrawal, Niraj Kumar Jha
  • Language: English

AI and Precision Oncology: Innovations in Diagnosis and Drug Development examines the transformative role of artificial intelligence and machine learning in oncology. This book a… Read more

World Book Day celebration

Where learning shapes lives

Up to 25% off trusted resources that support research, study, and discovery.

Explore resources

Description

AI and Precision Oncology: Innovations in Diagnosis and Drug Development examines the transformative role of artificial intelligence and machine learning in oncology. This book addresses the urgent need for early cancer diagnosis and effective therapeutic treatments, highlighting how technological advancements enable rapid analysis of large datasets to enhance patient outcomes. The content explores clinical applications of next-generation sequencing (NGS) integrated with AI technologies, covering risk prediction, disease detection, biomarker identification, and therapeutic target discovery. It emphasizes the importance of bioinformatics tools in analyzing NGS data and showcases AI-powered applications that improve cancer diagnosis and prognostication. For the academic audience, this book provides valuable insights into the latest advancements in AI and precision oncology. It equips researchers and clinicians with knowledge on personalized treatment strategies and recent clinical studies, ultimately enhancing understanding of how AI can revolutionize cancer care and improve patient management.

Key features

  • Provides an in-depth exploration of how artificial intelligence and machine learning are integrated into various aspects of oncology, including diagnosis, treatment planning, and patient management
  • Emphasizes the critical role of next-generation sequencing technologies in precision oncology, detailing their applications in risk prediction, biomarker identification, and therapeutic target discovery
  • Highlights how AI-driven tools can assist in tailoring personalized treatment options based on genetic, environmental, and lifestyle factors

Readership

Researchers, clinicians and postgraduate students in cancer research, bioinformatics, and artificial intelligence

Table of contents

1. Artificial Intelligence Applications in Clinical Oncology: A Comprehensive Overview

2. Artificial Intelligence Tools in Cancer Diagnosis and Treatment

3. The Role of Machine Learning in Personalized Cancer Care

4. The Role of Artificial Intelligence in Advancing Digital Pathology for Oncology

5. Transformative Applications of Artificial Intelligence in Digital Pathology: Bridging the Gap Between Research and Clinical Practice

6. Imaging in Neuro-Oncology: Clinical Uses of Radiomics and Artificial Intelligence

7. AI-Driven Digital Histopathology: Revolutionizing Prognostication and Treatment Efficacy in Cancer Care

8. Application of Artificial Intelligence Technology in Oncology: Towards the Establishment of Precision Medicine

9. Precision Oncology and Immune Therapy with the Use of AI and Digital Biomarkers in Precision Pathology

10. Evaluating Artificial Intelligence's (AI) Significance in Clinical Oncology: Practical Applications of Machine Learning for Radiotherapy

11. Regulatory Pathways for AI in Cancer Therapy

12. Challenges Associated with AI in Cancer Therapy

13. Current and Future Applications of Artificial Intelligence in Cancer Pathology: A Clinical Perspective

Product details

  • Edition: 1
  • Latest edition
  • Published: November 1, 2026
  • Language: English

About the editors

AS

Arun Kumar Singh

Arun Kumar Singh holds an M.Pharm in Pharmaceutics from Galgotias University, India, and serves as an Assistant Professor in the Department of Pharmacy at Vivekanand Global University. He is actively engaged in teaching and interdisciplinary research spanning nano-formulation, artificial intelligence, machine learning, big data analytics, IoT, blockchain, cancer biology, and neuroscience.

Mr. Singh has made substantial scholarly contributions, authoring one book with IOP Publishing, five book chapters with River Publishers, and 28 review articles in reputed journals, including high-impact publications in Biochimica et Biophysica Acta (BBA) – Reviews on Cancer.

In addition, he has authored and edited 58 books with leading publishers such as Elsevier, CRC Press, and Wiley. Known for his research acumen and leadership, Mr. Singh is committed to advancing pharmaceutical sciences through innovation and interdisciplinary collaboration, with a focus on impactful healthcare solutions.

Affiliations and expertise
Assistant Professor, Department of Pharmacy, Vivekanand Global University, Jaipur, Rajasthan, India

PA

Prateek Agrawal

Prateek Agrawal is professor and deputy dean at the School of Computer Science & Engineering, Lovely Professional University, Phagwara, Punjab, India. His research areas include natural language processing, computer vision, video processing, expert systems, deep learning applications, and other related topics. He is a senior member of IEEE and core member of IEEE India Council for Sustainable Development Activity, and is also a member of different reputed organizations like IET, MIR lab, and IAENG among others. Dr. Agarwal has published over 70 research papers in Scopus/SCIE indexed journals and conferences, 60 national patents, five edited books, and 10 book chapters. He is book series editor of the IOP series on next generation computing, and is a reviewer for many SCIE journals like Multimedia tools and Applications, Plos One, PeerJ, Oxford computer science, IEEE Access, and Ambient Intelligent & Humanized Computing.

Affiliations and expertise
Professor and Deputy Dean, School of Computer Science & Engineering, Lovely Professional University, Phagwara, Punjab, India

NJ

Niraj Kumar Jha

Dr. Niraj Kumar Jha is an Assistant Professor of Biotechnology at Galgotias University, India, with prior research affiliations at Chitkara University and Sharda University. His scholarly contributions include 200+ articles and an edited book. He has an H-index exceeding 50, reflecting significant impact in the biomedical sciences. He is a Member of the Royal Society of Biology, London, and has been recognized among the World’s Top 2% Scientists by Elsevier and Stanford University. Dr. Jha serves as Associate Editor for the Journal of Alzheimer’s Disease and IET Nanobiotechnology and as an editorial board member for several international journals. His research focuses on molecular mechanisms underlying neurodegenerative, cancer, and cardiovascular diseases, with particular emphasis on cellular signaling pathways and the therapeutic potential of natural products and synthetic small molecules.

Affiliations and expertise

Galgotias University, India

Affiliations and expertise
Galgotias University, India